Biosample

4DNBSVAXV6ND

released
View JSON

30 hour activated B cells

November 27th, 2018 at 5:37pm

Overview

Experiment Sets

Attribution

Details

Overview

None

LPS (Sigma) treatment (50.0 μg/mL, 30.0h)
(Chemical)
IL-4 (Sigma) treatment (2.5 ng/mL, 30.0h)
(Chemical)
anti-CD180 (RP105) antibody, BD PharMingen treatment (0.5 μg/mL, 30.0h)
(Chemical)

None

Biosource

B cell derived cell line - 4DNSRA3JY5KY

Primary cell

B cell derived cell line

None